Lakshminarayanan M - Search Results

1

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate.

Fontaine KR, Heo M, Harrigan EP, Shear CL, Lakshminarayanan M, Casey DE, Allison DB. Fontaine KR, et al. Among authors: lakshminarayanan m. Psychiatry Res. 2001 Apr 15;101(3):277-88. doi: 10.1016/s0165-1781(01)00234-7. Psychiatry Res. 2001. PMID: 11311931

2

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.

Daniel DG, Zimbroff DL, Potkin SG, Reeves KR, Harrigan EP, Lakshminarayanan M. Daniel DG, et al. Among authors: lakshminarayanan m. Neuropsychopharmacology. 1999 May;20(5):491-505. doi: 10.1016/S0893-133X(98)00090-6. Neuropsychopharmacology. 1999. PMID: 10192829 Clinical Trial.

3

Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial.

Zeiser R, Socié G, Schroeder MA, Abhyankar S, Vaz CP, Kwon M, Clausen J, Volodin L, Giebel S, Chacon MJ, Meyers G, Ghosh M, Deeren D, Sanz J, Morariu-Zamfir R, Arbushites M, Lakshminarayanan M, Barbour AM, Chen YB. Zeiser R, et al. Among authors: lakshminarayanan m. Lancet Haematol. 2022 Jan;9(1):e14-e25. doi: 10.1016/S2352-3026(21)00367-7. Lancet Haematol. 2022. PMID: 34971577 Clinical Trial.

4

First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.

Garrido-Laguna I, Krop I, Burris HA 3rd, Hamilton E, Braiteh F, Weise AM, Abu-Khalaf M, Werner TL, Pirie-Shepherd S, Zopf CJ, Lakshminarayanan M, Holland JS, Baffa R, Hong DS. Garrido-Laguna I, et al. Among authors: lakshminarayanan m. Int J Cancer. 2019 Oct 1;145(7):1798-1808. doi: 10.1002/ijc.32154. Epub 2019 Feb 23. Int J Cancer. 2019. PMID: 30680712 Free PMC article. Clinical Trial.

5

Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.

Munster P, Iannotti N, Cho DC, Kirkwood JM, Villaruz LC, Gibney GT, Hodi FS, Mettu NB, Jones M, Bowman J, Smith M, Lakshminarayanan M, O'Day S. Munster P, et al. Among authors: lakshminarayanan m. Cancer Res Commun. 2024 Mar 13;4(3):785. doi: 10.1158/2767-9764.CRC-24-0133. Cancer Res Commun. 2024. PMID: 38477691 Free PMC article. No abstract available.

6

Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.

Munster P, Iannotti N, Cho DC, Kirkwood JM, Villaruz LC, Gibney GT, Hodi FS, Mettu NB, Jones M, Bowman J, Smith M, Lakshminarayanan M, O'Day S. Munster P, et al. Among authors: lakshminarayanan m. Cancer Res Commun. 2023 Dec 19;3(12):2572-2584. doi: 10.1158/2767-9764.CRC-22-0461. Cancer Res Commun. 2023. PMID: 38115208 Free PMC article. Clinical Trial.

7

Co-occurrence of Amyloid Goiter and Adipose Metaplasia in a Patient With History of Pulmonary Tuberculosis: A Case Report.

Ahmed Khan Z, Ahmad S, Williams R, Gnanasambandam K, Lakshminarayanan M. Ahmed Khan Z, et al. Among authors: lakshminarayanan m. Cureus. 2023 Mar 11;15(3):e36008. doi: 10.7759/cureus.36008. eCollection 2023 Mar. Cureus. 2023. PMID: 37041909 Free PMC article.

8

PROTOCOL: An evidence and gap map of studies of implementation issues for interventions for those affected by and at risk of homelessness in high-income countries.

Singh S, Fitzpatrick S, Lakshminarayanan M, Saran A, Wood J, Yang T, White H. Singh S, et al. Among authors: lakshminarayanan m. Campbell Syst Rev. 2023 Feb 21;19(1):e1305. doi: 10.1002/cl2.1305. eCollection 2023 Mar. Campbell Syst Rev. 2023. PMID: 36911861 Free PMC article.

9

PROTOCOL: The effectiveness, implementation and cost effectiveness of mentoring programmes in reducing anti-social, violent and offending behaviour in children aged 17 years and below: A mixed method systematic review.

Lakshminarayanan M, Skinner G, Li J, Tolan P, Du Bois D, White H. Lakshminarayanan M, et al. Campbell Syst Rev. 2022 Nov 12;18(4):e1286. doi: 10.1002/cl2.1286. eCollection 2022 Dec. Campbell Syst Rev. 2022. PMID: 36908837 Free PMC article.

10

Histomorphologic Spectrum of Laryngeal Neuroendocrine Carcinoma: A Rare Case.

Lakshminarayanan M, Kurian A, Pai A. Lakshminarayanan M, et al. Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2477-2481. doi: 10.1007/s12070-020-02229-6. Epub 2020 Oct 20. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 36452838 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters